Medipharm Labs Valuation
MEDIF Stock | USD 0.04 0 2.27% |
Medipharm Labs seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Medipharm Labs Corp from analyzing the firm fundamentals such as Current Valuation of 3.05 M, profit margin of (2.07) %, and Return On Equity of -0.57 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Medipharm Labs' price fluctuation is out of control at this time. Calculation of the real value of Medipharm Labs Corp is based on 3 months time horizon. Increasing Medipharm Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medipharm otc stock is determined by what a typical buyer is willing to pay for full or partial control of Medipharm Labs Corp. Since Medipharm Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medipharm OTC Stock. However, Medipharm Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.043 | Real 0.0386 | Hype 0.04 |
The real value of Medipharm OTC Stock, also known as its intrinsic value, is the underlying worth of Medipharm Labs Corp OTC Stock, which is reflected in its stock price. It is based on Medipharm Labs' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medipharm Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medipharm Labs Corp helps investors to forecast how Medipharm otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medipharm Labs more accurately as focusing exclusively on Medipharm Labs' fundamentals will not take into account other important factors: Medipharm Labs Total Value Analysis
Medipharm Labs Corp is now forecasted to have takeover price of 3.05 M with market capitalization of 16.26 M, debt of 1.44 M, and cash on hands of 21.99 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medipharm Labs fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
3.05 M | 16.26 M | 1.44 M | 21.99 M |
Medipharm Labs Investor Information
The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medipharm Labs Corp recorded a loss per share of 0.14. The entity last dividend was issued on the 4th of October 2018. Based on the key indicators related to Medipharm Labs' liquidity, profitability, solvency, and operating efficiency, Medipharm Labs Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Medipharm Labs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medipharm Labs has an asset utilization ratio of 23.51 percent. This implies that the OTC Stock is making $0.24 for each dollar of assets. An increasing asset utilization means that Medipharm Labs Corp is more efficient with each dollar of assets it utilizes for everyday operations.Medipharm Labs Ownership Allocation
Medipharm Labs Corp maintains a total of 280.51 Million outstanding shares. Medipharm Labs Corp secures 3.92 % of its outstanding shares held by insiders and 7.05 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medipharm Labs Profitability Analysis
The company reported the revenue of 21.71 M. Net Loss for the year was (54.8 M) with loss before overhead, payroll, taxes, and interest of (13.42 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medipharm Labs' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medipharm Labs and how it compares across the competition.
About Medipharm Labs Valuation
The otc valuation mechanism determines Medipharm Labs' current worth on a weekly basis. Our valuation model uses a comparative analysis of Medipharm Labs. We calculate exposure to Medipharm Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medipharm Labs's related companies.MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.
8 Steps to conduct Medipharm Labs' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Medipharm Labs' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medipharm Labs' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medipharm Labs' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medipharm Labs' revenue streams: Identify Medipharm Labs' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medipharm Labs' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medipharm Labs' growth potential: Evaluate Medipharm Labs' management, business model, and growth potential.
- Determine Medipharm Labs' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medipharm Labs' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medipharm Labs Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medipharm Labs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 273.5 M | |
Forward Price Earnings | 26.8817 | |
Retained Earnings | -129.3 M |
Complementary Tools for Medipharm OTC Stock analysis
When running Medipharm Labs' price analysis, check to measure Medipharm Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medipharm Labs is operating at the current time. Most of Medipharm Labs' value examination focuses on studying past and present price action to predict the probability of Medipharm Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medipharm Labs' price. Additionally, you may evaluate how the addition of Medipharm Labs to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |